Login to Your Account

Taiwan’s TLC signs U.S./EU Sandoz deal for amphotericin B

By Dave Silver
Staff Writer

Tuesday, December 24, 2013
TAIPEI, Taiwan – Taiwan Liposome Co. Ltd. (TLC), of Taipei, recently signed a distribution agreement giving Sandoz AG, the generics drug affiliate of Novartis AG, of Basel, Switzerland, distribution rights in the European Union (EU) and U.S. for TLC’s generic version of Gilead Sciences Inc.’s Ambisome, a liposomal rendering of antifungal drug amphotericin B.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription